News

Xenon Pharmaceuticals Shares Insights at CNS Therapeutics Conference

Xenon Pharmaceuticals Shares Insights at CNS Therapeutics Conference

Xenon Pharmaceuticals Participation at CNS Therapeutics Conference

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a notable name in neuroscience-focused biopharmaceuticals, has recently announced its involvement in the highly anticipated BofA Securities 2024 CNS Therapeutics Virtual Conference. This event is scheduled for October 7, 2024, and is set to showcase critical developments and innovations in the field of central nervous system therapeutics.

Key Presentation Details

The conference will include a fireside chat featuring Xenon Pharmaceuticals, where executives will discuss the company’s pipeline and advancements aimed at significantly enhancing patient care. The presentation is particularly noteworthy for those interested in neurological and psychiatric disorders.

Date and Time Highlights

The fireside chat is scheduled for Monday, October 7, 2024, at 11:40 am Eastern Time. Interested participants can access the event through a live webcast available on the Investors section of Xenon's official website. This platform ensures that both attendees and stakeholders can engage with the company's insights and progress.

About Xenon Pharmaceuticals

Xenon Pharmaceuticals is driven by a mission to discover, develop, and distribute innovative therapeutics that improve the lives of individuals facing complex neurological challenges. The company is focused on addressing significant unmet medical needs, particularly in areas like epilepsy and depression.

Innovative Product Pipeline

One of Xenon’s leading candidates is Azetukalner, a groundbreaking Kv7 channel opener. This product stands out as a clinically validated potassium channel modulator and is currently in late-stage clinical development for multiple indications. Through such innovations, Xenon is paving the way for new treatment modalities that could transform patient outcomes in neurology.

Company Commitment

Xenon Pharmaceuticals remains committed to advancing research and development efforts aimed at unveiling novel therapeutic options for patients enduring neurological disorders. Their innovative spirit continues to drive various projects that seek to improve patient care and healing in the realm of neuroscience.

Company Leadership and Impact

The leadership at Xenon is comprised of experienced professionals dedicated to steering the company toward breakthrough achievements in therapeutic interventions. As the company progresses, it aims to deliver solutions that meet the urgent requests of healthcare providers and patients alike.

Contact Information

For those wanting to connect with Xenon’s team, contact details are as follows: For investors, reach out to Chad Fugere, Vice President of Investor Relations, at (857) 675-7275 or via email. Media inquiries can be directed to Colleen Alabiso, Senior Vice President of Corporate Affairs, at (617) 671-9238.

Frequently Asked Questions

What is the focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals specializes in developing innovative therapeutics for neurological and psychiatric disorders.

When is Xenon Pharmaceuticals participating in the CNS Therapeutics conference?

The company will present on October 7, 2024, at the BofA Securities Virtual Conference.

What is Azetukalner?

Azetukalner is Xenon's lead Kv7 channel opener, currently in late-stage clinical development for multiple indications.

How can I watch the Xenon presentation?

The presentation will be available via live webcast on the Investors section of Xenon’s website.

Who should I contact for investor relations at Xenon?

Chad Fugere is the appropriate contact for investor inquiries at Xenon Pharmaceuticals.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ravi Bhalla Snags Top Franchise Award with $5M Milestone

Updated Category News Views 62

From Local Fixture to National Recognition Ravi Bhalla, owner of PostalAnnex #16006 in Calabasas, CA, takes home the Crystal Award at Annex Brands' 2026 National Convention in Vegas. And let me tell you, this isn't just some shiny trophy to stuff in a display case. This is major. Shattering Sales Goals What's the big kerfuffle over? It's this: Bhalla cracked the $5...

Continue Reading
EAF Relief Fund Launches After Learjet Disaster

Updated Category News Views 103

Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...

Continue Reading
Syra Health Hits Record Revenue, Sustains Growth

Updated Category News Views 104

Syra Health Reports Stellar Q3 Performance Folks, let's dive right into the figures: Syra Health's Q3 2026 performance is nothing short of a powerhouse display. We're talking about a jaw-dropping 52% surge in revenue compared to the same period last year, climbing to a record $2.6 million. It's not often you see a company swing its EPS from a loss of $(0.02) to a positive...

Continue Reading
GreenCore's Agentic Shopping Hub: Disrupting FMCG Market

Updated Category News Views 59

GreenCore's Bold Move in FMCG Retail Just when you thought retail couldn't get any more futuristic, here comes GreenCore Solutions Corp. (GSC) shaking up the game with their Agentic Shopping Hub. For the uninitiated, we're not just talking about another e-commerce gimmick—this is a cultural shift. FMCG brands are being told to 'bring their agent' into a realm where AI...

Continue Reading
AI Shift: From Tech Marvels to Practical Uses

Updated Category News Views 55

A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...

Continue Reading
Drone Tech Transforms Polish Mountain Rescues

Updated Category News Views 81

Innovation Meets Mountains You think search and rescue is all dog teams and heroic treks? Think again. Poland's mountain rescue team, known as TOPR, is flipping the script. Nestled in the rugged Tatra Mountains, they're leading a drone tech revolution that's shifting the game entirely. Drones: From Base to Peak in Minutes TOPR's team isn't just experimenting; they've...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 104

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
Midterms Stir Markets; Event Contracts Fuel Q3 Gains

Updated Category News Views 67

Midterms Mingle with Financial Markets Folks, throw those ballots into the ring, because today the midterms are kicking things off and boy, are they shaking up the game on these prediction markets. Traders and exchanges are on their toes, and the money's flowing like cold brew in July. Robinhood, Intercontinental Exchange, CME Group, and others reported noticeable ripples...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 25

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
Chicken Salad Chick Expands in Texas with New Opening

Updated Category News Views 131

A New Flavor in Town: Chicken Salad Chick Opens in Texas When you hear about chicken salad, you probably don't think of Texas as its new frontier. But here we are, with Chicken Salad Chick spreading its wings in Victoria County. Come November 18, the folks down there will be in for a treat with the grand opening of the nation’s only fast casual chicken salad restaurant...

Continue Reading

Top 5 Most Recently Viewed Articles

Passage Bio Showcases Innovations in Neurodegenerative Treatment

Updated Category News Views 66

Innovative Approaches in Neurodegenerative Disease Treatment Passage Bio, Inc. (NASDAQ: PASG) is making waves in the field of genetic medicines aimed at transforming the lives of those battling neurodegenerative diseases. With a firm commitment to innovation, this clinical stage company is at the forefront of research and development, striving to bring hope through...

Continue Reading
Experience the Thrilling Public Demo of Autogun Heroes Now!

Updated Category News Views 182

Unleashing the Excitement of Autogun Heroes: Supercharged Step into the vibrant universe of gaming nostalgia with the public demo of Autogun Heroes: Supercharged, a stunning tribute to classic shoot 'em up adventures. This demo, crafted by Nitro Games, allows enthusiasts to immerse themselves in exhilarating gameplay right now, providing a taste of what's to come. About...

Continue Reading
Biodexa Pharmaceuticals Adjusts ADR Ratio for Market Compliance

Updated Category News Views 90

Biodexa Pharmaceuticals Announces ADR Ratio Change Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company, has recently announced a change in the ratio of its American Depositary Receipts (ADR). This adjustment is intended to comply with Nasdaq's minimum bid price requirement. The ratio will change from four hundred ordinary shares per ADR...

Continue Reading
DENSO's 2026 Supplier Awards Emphasize Resiliency

Updated Category News Views 32

Seems like everyone's got a trophy these days, but DENSO's 2026 North America Business Partner Awards aren't just handing out gold stars for showing up. These awards are a solid nod to suppliers that've been crushing it through innovation and resilience. Held on June 17, 2026, this annual hoopla wasn't just another back-patting fest; it was a real reminder that...

Continue Reading
Unlocking New Opportunities with Impartner on Azure Marketplace

Updated Category News Views 718

Impartner's PRM Platform Available Now on Azure Marketplace Customers utilizing Microsoft Azure now have access to Impartner's Partner Relationship Management (PRM) platform. This integration allows businesses to leverage Azure's scalability, reliability, and agility, facilitating growth in partner programs while enhancing overall business strategies. Streamlined...

Continue Reading